Shikiar Asset Management Inc. grew its stake in Core Scientific, Inc. (NASDAQ:CORZ - Free Report) by 27.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 95,250 shares of the company's stock after purchasing an additional 20,250 shares during the period. Shikiar Asset Management Inc.'s holdings in Core Scientific were worth $1,338,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. ORG Wealth Partners LLC grew its position in Core Scientific by 0.3% during the 4th quarter. ORG Wealth Partners LLC now owns 8,986,651 shares of the company's stock worth $126,262,000 after acquiring an additional 26,649 shares during the last quarter. Parsifal Capital Management LP grew its holdings in shares of Core Scientific by 3.9% during the third quarter. Parsifal Capital Management LP now owns 5,412,825 shares of the company's stock worth $64,196,000 after purchasing an additional 204,314 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of Core Scientific by 26.7% during the third quarter. Geode Capital Management LLC now owns 5,276,573 shares of the company's stock worth $62,594,000 after purchasing an additional 1,113,285 shares during the last quarter. State Street Corp increased its stake in shares of Core Scientific by 17.0% in the third quarter. State Street Corp now owns 4,006,922 shares of the company's stock valued at $47,522,000 after buying an additional 583,493 shares during the period. Finally, Taconic Capital Advisors LP raised its holdings in Core Scientific by 178.7% in the 3rd quarter. Taconic Capital Advisors LP now owns 2,717,462 shares of the company's stock valued at $32,229,000 after buying an additional 1,742,462 shares during the last quarter.
Insiders Place Their Bets
In other news, Director Yadin Rozov sold 105,000 shares of the business's stock in a transaction that occurred on Friday, November 22nd. The stock was sold at an average price of $18.11, for a total transaction of $1,901,550.00. Following the completion of the sale, the director now owns 345,239 shares in the company, valued at $6,252,278.29. The trade was a 23.32 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Todd M. Duchene sold 25,000 shares of the company's stock in a transaction dated Wednesday, November 20th. The stock was sold at an average price of $17.10, for a total transaction of $427,500.00. Following the completion of the sale, the insider now owns 1,661,474 shares in the company, valued at $28,411,205.40. This represents a 1.48 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 348,241 shares of company stock worth $5,436,802.
Core Scientific Stock Performance
Shares of NASDAQ:CORZ traded up $0.37 during mid-day trading on Friday, hitting $15.00. The company had a trading volume of 8,879,625 shares, compared to its average volume of 8,324,011. Core Scientific, Inc. has a one year low of $2.61 and a one year high of $18.63. The firm has a fifty day moving average price of $15.63 and a 200 day moving average price of $12.79.
Analyst Ratings Changes
A number of research firms have weighed in on CORZ. Canaccord Genuity Group started coverage on shares of Core Scientific in a report on Monday, September 23rd. They set a "buy" rating and a $16.00 target price on the stock. Canaccord Genuity Group reissued a "buy" rating and issued a $17.00 price objective on shares of Core Scientific in a research note on Thursday, November 7th. Roth Mkm initiated coverage on Core Scientific in a research report on Friday, November 15th. They set a "buy" rating and a $25.50 target price for the company. HC Wainwright lifted their target price on Core Scientific from $15.00 to $17.00 and gave the stock a "buy" rating in a report on Thursday, November 7th. Finally, Cantor Fitzgerald reissued an "overweight" rating and issued a $20.00 price target on shares of Core Scientific in a research note on Thursday, October 3rd. Thirteen research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus price target of $18.46.
Read Our Latest Stock Analysis on CORZ
About Core Scientific
(
Free Report)
Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.
Further Reading
Before you consider Core Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Scientific wasn't on the list.
While Core Scientific currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
